In 2023, the mortality from liver malignant neoplasms in Japan was undisclosed, but in 2024, it is projected to be 22.65 thousand deaths. The forecast indicates a decreasing trend: 22.12 in 2025, 21.59 in 2026, 21.07 in 2027, and 20.55 thousand deaths in 2028, showing a year-on-year decline.
- Year-over-year percentage decrease from 2024 to 2025 is approximately 2.34%.
- From 2025 to 2026, the decline is around 2.39%.
- The decrease from 2026 to 2027 is about 2.41%.
- Finally, the reduction from 2027 to 2028 is roughly 2.47%.
- The compound annual growth rate (CAGR) from 2024 to 2028 is approximately -2.20%.
The consistent decrease in mortality suggests improvements in medical treatment and early detection. Future trends to watch include breakthroughs in liver cancer treatment, lifestyle changes, public health initiatives to manage risk factors like hepatitis, and advancements in genetic research and personalized medicine that could further reduce mortality rates.
